Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.98
Delayed Data
As of 9:46am ET
 -0.02 / -1.00%
Today’s Change
1.72
Today|||52-Week Range
3.09
-5.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$34.4M

Company Description

Novogen Ltd. engages in the business of pharmaceutical drug development. It engages in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. Novogen was founded by Graham Edmund Kelly in March 1994 and is headquartered in Hornsby, Australia.

Contact Information

Novogen Ltd.
20 George Street
Hornsby New South Wales (nsw) 2077
P:(129) 472-4101
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

James GarnerChief Executive Officer & Director
Cristyn HumphreysChief Financial Officer
David BrownChief Scientific Officer
Kate HillSecretary
Kimberley LilischkisManager-Clinical & Regulatory Affairs